Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults With Transplant‐ineligible Multiple Myeloma: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434607/1/Interventions_for_improving_adherence_to_ocular_hypotensive_therapy:_Cochrane_systematic_review. Accessed 25 April 2024.
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/1/Interventions_for_improving_adherence_to_ocular_hypotensive_therapy:_Cochrane_systematic_review. Accessed April 25, 2024.
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/1/Interventions_for_improving_adherence_to_ocular_hypotensive_therapy:_Cochrane_systematic_review
Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults With Transplant‐ineligible Multiple Myeloma: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/1/Interventions_for_improving_adherence_to_ocular_hypotensive_therapy:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis
ID - 434607
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/1/Interventions_for_improving_adherence_to_ocular_hypotensive_therapy:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -